500 related articles for article (PubMed ID: 14597417)
21. Integrin alphavbeta3 mediates platelet-derived growth factor-BB-stimulated collagen gel contraction in cells expressing signaling deficient integrin alpha2beta1.
Grundström G; Mosher DF; Sakai T; Rubin K
Exp Cell Res; 2003 Dec; 291(2):463-73. PubMed ID: 14644167
[TBL] [Abstract][Full Text] [Related]
22. Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis.
Perruzzi CA; de Fougerolles AR; Koteliansky VE; Whelan MC; Westlin WF; Senger DR
J Invest Dermatol; 2003 Jun; 120(6):1100-9. PubMed ID: 12787141
[TBL] [Abstract][Full Text] [Related]
23. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
[TBL] [Abstract][Full Text] [Related]
24. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
[TBL] [Abstract][Full Text] [Related]
25. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen.
Fishman DA; Kearns A; Chilukuri K; Bafetti LM; O'Toole EA; Georgacopoulos J; Ravosa MJ; Stack MS
Invasion Metastasis; 1998; 18(1):15-26. PubMed ID: 10207247
[TBL] [Abstract][Full Text] [Related]
26. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
Alonso-Escolano D; Strongin AY; Chung AW; Deryugina EI; Radomski MW
Br J Pharmacol; 2004 Jan; 141(2):241-52. PubMed ID: 14691052
[TBL] [Abstract][Full Text] [Related]
27. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
[TBL] [Abstract][Full Text] [Related]
28. beta1-Integrins mediate enhancement of airway smooth muscle proliferation by collagen and fibronectin.
Nguyen TT; Ward JP; Hirst SJ
Am J Respir Crit Care Med; 2005 Feb; 171(3):217-23. PubMed ID: 15502110
[TBL] [Abstract][Full Text] [Related]
29. VANGL2 interacts with integrin αv to regulate matrix metalloproteinase activity and cell adhesion to the extracellular matrix.
Jessen TN; Jessen JR
Exp Cell Res; 2017 Dec; 361(2):265-276. PubMed ID: 29097183
[TBL] [Abstract][Full Text] [Related]
30. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.
Giannelli G; Bergamini C; Fransvea E; Marinosci F; Quaranta V; Antonaci S
Lab Invest; 2001 Apr; 81(4):613-27. PubMed ID: 11304581
[TBL] [Abstract][Full Text] [Related]
31. Monocyte Adhesion, Migration, and Extracellular Matrix Breakdown Are Regulated by Integrin αVβ3 in
Brilha S; Wysoczanski R; Whittington AM; Friedland JS; Porter JC
J Immunol; 2017 Aug; 199(3):982-991. PubMed ID: 28646039
[TBL] [Abstract][Full Text] [Related]
32. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
33. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration.
Takino T; Miyamori H; Watanabe Y; Yoshioka K; Seiki M; Sato H
Cancer Res; 2004 Feb; 64(3):1044-9. PubMed ID: 14871836
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase activity synergizes with alpha2beta1 integrins to enhance collagen remodeling.
Phillips JA; Bonassar LJ
Exp Cell Res; 2005 Oct; 310(1):79-87. PubMed ID: 16098964
[TBL] [Abstract][Full Text] [Related]
35. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes.
Forsyth CB; Pulai J; Loeser RF
Arthritis Rheum; 2002 Sep; 46(9):2368-76. PubMed ID: 12355484
[TBL] [Abstract][Full Text] [Related]
36. Human cervical tumor cell (SiHa) surface alphavbeta3 integrin receptor has associated matrix metalloproteinase (MMP-2) activity.
Chattopadhyay N; Mitra A; Frei E; Chatterjee A
J Cancer Res Clin Oncol; 2001 Nov; 127(11):653-8. PubMed ID: 11710594
[TBL] [Abstract][Full Text] [Related]
37. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical.
Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS
Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401
[TBL] [Abstract][Full Text] [Related]
38. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions.
Préaux AM; Mallat A; Nhieu JT; D'Ortho MP; Hembry RM; Mavier P
Hepatology; 1999 Oct; 30(4):944-50. PubMed ID: 10498646
[TBL] [Abstract][Full Text] [Related]
40. Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.
Majkowska I; Shitomi Y; Ito N; Gray NS; Itoh Y
J Biol Chem; 2017 Apr; 292(16):6633-6643. PubMed ID: 28270508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
